Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown ...Middle East

GREENFIELD, Ind., May 5, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the sale of certain future tiered royalties and commercial milestones associated with XDEMVY® (lotilaner ophthalmic solution) 0.25%, for the human health application of lotilaner,...

Read More Details
Finally We wish PressBee provided you with enough information of ( Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown )

Also on site :

• Giveaway: Enter to win tickets for ‘Hello, Dolly!’
• MoneyFellows raises $13M to take its group savings model outside Egypt
• Denver police investigating hit-and-run crash involving multiple cars